cbdMD, Inc. reported its financial results for the third quarter of fiscal 2025, revealing a decline in revenue and continued operational challenges. For the three months ended June 30, 2025, the company generated total net sales of $4.6 million, a decrease of 12% from $5.2 million in the same period last year. The nine-month revenue figures also reflected a decline, with total net sales of $14.5 million compared to $14.9 million in the prior year. The company attributed these declines primarily to a drop in direct-to-consumer sales and regulatory uncertainties affecting wholesale accounts.
The company's gross profit for the third quarter was $2.8 million, representing a gross margin of 61.5%, down from 65.8% in the previous year. Operating expenses remained relatively stable at $3.7 million, leading to a loss from operations of $904,686, compared to a loss of $382,028 in the same quarter of the previous year. For the nine-month period, the operating loss improved significantly to $1.5 million from $3 million, indicating some progress in cost management despite ongoing challenges.
In terms of strategic developments, cbdMD has made significant organizational changes, including a restructuring of its marketing team to enhance customer acquisition efforts. The company also launched its new THC-infused beverage brand, Oasis, which has received positive consumer feedback and is expanding its distribution across several states. This product is part of a broader strategy to tap into the rapidly growing hemp-derived beverage market, which is projected to reach $4.1 billion by 2028.
Operationally, cbdMD reported a cash position of approximately $1.1 million as of June 30, 2025, down from $2.4 million at the end of the previous fiscal year. The company has also seen a reduction in its accumulated deficit, which stood at $179.1 million, down from $182.1 million. The company’s working capital improved to $2 million, reflecting a significant turnaround from a negative working capital position of $2.2 million in the prior year. However, cbdMD continues to face liquidity challenges and has indicated that its ability to continue as a going concern is dependent on improving profitability and securing additional funding.
Looking ahead, cbdMD remains focused on optimizing its product portfolio and enhancing marketing strategies to drive revenue growth. The company is also actively engaging in regulatory discussions to navigate the evolving legal landscape surrounding hemp-derived products. Despite the challenges, management expressed optimism about the potential for recovery and growth, particularly with the recent product launches and strategic adjustments aimed at improving operational efficiency and market presence.
About cbdMD, Inc.
cbdMD, Inc. develops and distributes hemp-derived dietary supplements, including CBD products, topicals, and functional mushroom blends. Its brands, cbdMD, Paw CBD, and ATRx Labs, serve consumers and pet markets through e-commerce, retail, and international channels. The company emphasizes product quality, scientific research, and brand reputation to differentiate in a competitive, regulatory-sensitive industry focused on health, wellness, and functional ingredients.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.